Core Laboratories Inc. (NYSE: CLB) last traded at $9.99, down 1.04% on the session. The quote above updates while this page is open; the figures below are drawn from Core Laboratories Inc.’s own filings and are restated only when a new one is published.
Core Laboratories Inc. trades on NYSE under the ticker CLB. Its market capitalisation is $458.16 million.
Valuation measures for Core Laboratories Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $458.16M |
|---|---|
| Enterprise value | $743.43M |
| P/E ratio | 19.20 |
| Price / sales | 0.88 |
| Price / book | 1.68 |
| Beta | 0.85 |
Trailing-twelve-month figures tagged in Core Laboratories Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $519.18M |
|---|---|
| Net income (TTM) | $24.35M |
| EPS (TTM) | $0.520 |
| Gross margin | 19.52% |
| Operating margin | 9.21% |
| Return on equity | 8.93% |
| Cash | $22.73M |
Range and volume for CLB over the past 52 weeks.
| 52-week high | $20.36 |
|---|---|
| 52-week low | $9.63 |
| Volume | 83.2K |
| Average volume | 610.5K |
| Previous close | $10.09 |
Dividend history for Core Laboratories Inc. over the trailing twelve months.
| Dividend yield | 0.40% |
|---|---|
| Dividend per share (TTM) | $0.0400 |
| Payout ratio | 7.69% |
Invest a chosen dollar amount in Core Laboratories Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CLB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.